How do I implement a whole blood program for massively bleeding patients?

Transfusion

Volumn 58, Issue 3, 2018, Pages 622-628

  Yazer, Mark H ^a   Cap, Andrew P ^b   Spinella, Philip C ^c   Alarcon, Louis ^d   Triulzi, Darrell J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIBODY; RHESUS D ANTIBODY;

ANTIBODY TITER; ARTICLE; BLEEDING; BLOOD DONOR; BLOOD GROUP A; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP O; BLOOD TRANSFUSION; HEMOLYSIS; HUMAN; PLASMA TRANSFUSION; THROMBOCYTE TRANSFUSION; BLOOD; HEALTH CARE DELIVERY; ORGANIZATION AND MANAGEMENT; PROCEDURES; STANDARDS; TRANSFUSION RELATED ACUTE LUNG INJURY; UNITED STATES;

ABO BLOOD-GROUP SYSTEM; BLOOD TRANSFUSION; DELIVERY OF HEALTH CARE; HEMORRHAGE; HUMANS; TRANSFUSION-RELATED ACUTE LUNG INJURY; UNITED STATES;

EID: 85043491396     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14474     Document Type: Article

References (37)

1. Murdock AD, Berséus O, Hervig T, et al. Whole blood: the future of traumatic hemorrhagic shock resuscitation. Shock 2014;41 Suppl 1:62-9.
2. Spinella PC, Cap AP. Whole blood: back to the future. Curr Opin Hematol 2016;23:536-42.
3. Zielinski MD, Stubbs JR, Berns KS, et al. Prehospital blood transfusion programs: capabilities and lessons learned. J Trauma Acute Care Surg 2017;82:S70-8.
4. Spinella PC, Cap AP. Prehospital hemostatic resuscitation to achieve zero preventable deaths after traumatic injury. Curr Opin Hematol 2017;24:529-35.
5. Shackelford SA, Del Junco DJ, Powell-Dunford N, et al. Association of prehospital blood product transfusion during medical evacuation of combat casualties in Afghanistan with acute and 30-day survival. JAMA 2017;318:1581-91.
6. Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015;313:471-82.
7. Davenport RA, Brohi K. Cause of trauma-induced coagulopathy. Curr Opin Anaesthesiol 2016;29:212-9.
8. Pidcoke HF, McFaul SJ, Ramasubramanian AK, et al. Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time. Transfusion 2013;53 Suppl 1:137S-49S.
9. Reddoch KM, Pidcoke HF, Montgomery RK, et al. Hemostatic function of apheresis platelets stored at 4°C and 22°C. Shock 2014;41 Suppl 1:54-61.
10. Nair PM, Pandya SG, Dallo SF, et al. Platelets stored at 4°C contribute to superior clot properties compared to current standard-of-care through fibrin-crosslinking. Br J Haematol 2017;178:119-29.
11. Nair PM, Pidcoke HF, Cap AP, et al. Effect of cold storage on shear-induced platelet aggregation and clot strength. J Trauma Acute Care Surg 2014;77:S88-93.
12. Manno CS, Hedberg KW, Kim HC, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 1991;77:930-6.
13. Becker GA, Tuccelli M, Kunicki T, et al. Studies of platelet concentrates stored at 22 C and 4 C. Transfusion 1973;13:61-8.
14. Meyer DE, Vincent LE, Fox EE, et al. Every minute counts: time to delivery of initial massive transfusion cooler and its impact on mortality. J Trauma Acute Care Surg 2017;83:19-24.
15. Yazer MH, Seheult JN, Kleinman S, et al. Who's afraid of incompatible plasma? A balanced approach to the safe transfusion of blood products containing ABO-incompatible plasma. Transfusion 2018;58:532-381.
16. Belin TR, Yazer MH, Meledeo MA, et al. An evaluation of methods for producing low-titer group O whole blood to support military trauma resuscitation. J Trauma Acute Care Surg 2017;82:S79-s86.
17. Josephson CD, Castillejo MI, Grima K, et al. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies. Transfus Apher Sci 2010;42:83-8.
18. Lozano M, Cid J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003;17:57-68.
19. Bahr MP, Yazer MH, Triulzi DJ, et al. Whole blood for the acutely haemorrhaging civilian trauma patient: a novel idea or rediscovery? Transfus Med 2016;26:406-14.
20. Seheult JN, Triulzi DJ, Alarcon LH, et al. Measurement of haemolysis markers following transfusion of uncrossmatched, low-titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre. Transfus Med 2017;27:30-5.
21. Dunbar NM, Yazer MH; Biomedical Excellence for Safer Transfusion (BEST) Collaborative and the STAT Study Investigators. Safety of the use of group A plasma in trauma: the STAT study. Transfusion 2017;57:1879-84.
22. Sprogoe U, Yazer MH, Rasmussen MH, et al. Minimal variation in anti-A and -B titers among healthy volunteers over time: implications for the use of out-of-group blood components. J Trauma Acute Care Surg 2017;82:S87-90.
23. Yazer MH, Triulzi DJ. Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion 2007;47:2197-201.
24. Frohn C, Dümbgen L, Brand JM, et al. Probability of anti-D development in D-patients receiving D+ RBCs. Transfusion 2003;43:893-8.
25. Gonzalez-Porras JR, Graciani IF, Perez-Simon JA, et al. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Transfusion 2008;48:1318-24.
26. Selleng K, Jenichen G, Denker K, et al. Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study. Lancet Haematol 2017;4:e218-24.
27. Meyer E, Uhl L. A case for stocking O D+ red blood cells in emergency room trauma bays. Transfusion 2015;55:791-5.
28. Miraflor E, Yeung L, Strumwasser A, et al. Emergency uncrossmatched transfusion effect on blood type alloantibodies. J Trauma Acute Care Surg 2012;72:48-52; discussion 52-3.
29. Dutton RP, Shih D, Edelman BB, et al. Safety of uncrossmatched type-O red cells for resuscitation from hemorrhagic shock. J Trauma 2005;59:1445-9.
30. Gunson HH, Stratton F, Cooper DG, et al. Primary immunization of Rh-negative volunteers. Br Med J 1970;1:593-5.
31. Urbaniak SJ, Robertson AE. A successful program of immunizing Rh-negative male volunteers for anti-D production using frozen/thawed blood. Transfusion 1981;21:64-9.
32. Pollack W, Ascari WQ, Crispen JF, et al. Studies on Rh prophylaxis. II. Rh immune prophylaxis after transfusion with Rh-positive blood. Transfusion 1971;11:340-4.
33. Nathens AB, Nester TA, Rubenfeld GD, et al. The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock 2006;26:342-7.
34. Utter GH, Nathens AB, Lee TH, et al. Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients. Transfusion 2006;46:1863-9.
35. Watkins TR, Rubenfeld GD, Martin TR, et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Crit Care Med 2008;36:1493-9.
36. Phelan HA, Sperry JL, Friese RS. Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients. J Surg Res 2007;138:32-6.
37. Yazer MH, Glackin EM, Triulzi DJ, et al. The effect of stationary versus rocked storage of whole blood on red blood cell damage and platelet function. Transfusion 2016;56:596-604.